Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study | Zendy

AI Assistant Blog Pricing

Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.